ITMCTR2000003193招募中未知
Clinical Research of Treatment of Type 2 Diabetes With Jianpi Huazhuo Massage
anjing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 35 至 80(—)
- 性别
- All
入选标准
- •1. At the same time, it complies with T2DM diagnostic standards for Chinese and Western medicine;
- •2. Agree to participate in this study and be able to sign informed consent;
- •3. Between 35 and 80 years old;
- •4. Have not received massage therapy for type 2 diabetes within the past 2 weeks and have not participated in other ongoing clinical studies.
排除标准
- •1. Type I diabetes, adult delayed-onset autoimmune diabetes (LADA), gestational diabetes (GDM), and other secondary diabetes;
- •2. Complicated with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system;
- •3. Complicated with acute complications such as ketoacidosis and infection;
- •4. Pregnancy and lactation;
- •5. Alcoholism or psychotropic substance abuse and mental disorders;
- •6. The type and dose of medication changed within 1 month before the trial (including hypoglycemic, hypotensive and lipid-lowering drugs);
- •7. Participate in other clinical trials within the past year and take drugs that affect glucose and lipid metabolism within the past month;
- •8. Intestinal diseases and taking antibiotics or micro-ecological drinks within 1 month before the test;
- •9. 2 months before the test, the weight change is greater than 5%;
- •10. Infectious diseases are not suitable for massage therapy.
- •Any one of the above items shall be excluded.
研究者
相似试验
已完成
不适用
Study on insulin treatment for type 2 diabetes performed by general practitionersType 2 diabetes mellitusJPRN-UMIN000011287General incorporated Tokyo Physicians Association.100
已完成
1 期
Treating To Target in Type 2 diabetesType 2 diabetesNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN51125379ovo Nordisk Limited (UK)700
招募中
不适用
Survey research for patients with type 2 diabetesType 2 diabetesJPRN-UMIN000041686Tokyo Medical University400
已完成
3 期
Double blind, randomised, comparative, multicentre, parallel-group study design to evaluate the effects of Pioglitazone on cardiovascular risk markers in type 2 diabetes mellitusACTRN12608000534381Takeda Italia Farmaceutici S.p.A.100
进行中(未招募)
不适用
Testing a non-invasive smartphone application to predict sugar levels in the bloodISRCTN15977623Bioepic Ltd72
